Target- |
MechanismCell membrane function inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismSARS-CoV-2 antigen inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Centre of Excellence for Biosensors, Instrumentation and Process Control
0 Patents (Medical) associated with Centre of Excellence for Biosensors, Instrumentation and Process Control
100 Deals associated with Centre of Excellence for Biosensors, Instrumentation and Process Control
100 Translational Medicine associated with Centre of Excellence for Biosensors, Instrumentation and Process Control